Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

By HospiMedica International staff writers
Posted on 22 Jul 2025

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense. More...

These autoantibodies can go undetected for extended periods, making diagnosis difficult and delaying critical treatment. Traditional testing methods can be slow, expensive, and insensitive to trace levels of harmful antibodies, especially in the early stages of illness. Now, researchers have developed a rapid, highly sensitive paper-based test that enables one-step detection of these autoantibodies in under 10 minutes.

The paper-based diagnostic device called the 3D-osPAD (3D origami signal-amplified paper-based analytical device) has been developed by scientists at National Taiwan University (Taipei, Taiwan) and uses a folded 3D paper structure combined with gold nanoparticle signal amplification to enhance detection. All necessary reagents are preloaded within layered compartments, which allows the assay to initiate automatically once a small drop of diluted blood serum is added. The design enables a one-step, streamlined process that does not require expensive laboratory equipment or specialized training, making it accessible for both hospital and remote clinical settings. This technological innovation significantly improves test sensitivity achieving a tenfold increase over conventional detection methods while delivering results in just 10 minutes.

In the study published in Biosensors and Bioelectronics, the 3D-osPAD was clinically validated and demonstrated 100% sensitivity and specificity in accurately identifying patients with adult-onset immunodeficiency caused by anti-IFN-γ autoantibodies. In addition to its clinical accuracy, the portable and user-friendly design of the test supports applications in rapid diagnosis, treatment planning, and recovery monitoring. The researchers plan to further develop similar user-friendly and highly sensitive analytical tools for on-site diagnostics, especially in resource-limited environments.

Related Links:
National Taiwan University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.